TANG Capital Management LLC, 10% Owner, Chief Executive Officer, Officer, Chief Financial Officer at Odonate Therapeutics, Inc. (ODT), sold 4,494,262 shares at $2.66 ($9.5M) on 2021-11-17, disclosed to the SEC on 2021-11-19.
Open-market sale of $9.5M ODT by 10% Owner, Chief Executive Officer, Officer, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.99 | 31,151 | $62K | 0.7% |
| 2 | $1.99 | 31,151 | $62K | 0.7% |
| 3 | $2.02 | 500,000 | $1.0M | 10.6% |
| 4 | $2.20 | 287,577 | $633K | 6.6% |
| 5 | $2.20 | 287,577 | $633K | 6.6% |
| 6 | $2.66 | 468,849 |
| $1.2M |
| 13.1% |
| 7 | $2.66 | 468,849 | $1.2M | 13.1% |
| 8 | $1.88 | 500,000 | $940K | 9.9% |
| 9 | $1.89 | 381,842 | $722K | 7.6% |
| 10 | $1.89 | 381,842 | $722K | 7.6% |
| 11 | $1.97 | 212,423 | $418K | 4.4% |
| 12 | $1.97 | 212,423 | $418K | 4.4% |
| 13 | $1.92 | 365,289 | $701K | 7.4% |
| 14 | $1.92 | 365,289 | $701K | 7.4% |
| Total | $2.12 avg | 4,494,262 | $9.5M | 100% |
| Filing → |
| RAIN | BUY | 2023-06-01 | $2.1M | — | Filing → |
| JNCE | BUY | 2023-03-14 | $151K | — | Filing → |
| LJPC | BUY | 2021-06-01 | $2.2M | — | Filing → |